Belvedere Trading
RVPH

Belvedere Trading’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Belvedere Trading’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-235
Closed -$24.2K – 919
2023
Q4 		$24.2K Sell
235
-3,920
-94% -$352K ﹤0.01% 634
2023
Q3 		$406K Buy
4,155
+3,435
+477% +$320K ﹤0.01% 137
2023
Q2 		$84.4K Buy
720
+545
+311% +$69.1K ﹤0.01% 460
2023
Q1 		$14.7K Buy
+175
New +$15.3K ﹤0.01% 729

Other funds holding RVPH

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
ECM
EMC Capital Management Houston, Texas $253M AUM

Belvedere Trading's RVPH Position: Q1 2024 in Review

Belvedere Trading sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2024, closing a stake of 166 shares — an estimated $17.1K sold.

Belvedere Trading first reported a position in RVPH in Q1 2023 and held it in 4 quarters. The position peaked at $242K in Q3 2023. 28 funds tracked by Wall St. Rank hold RVPH as of Q1 2024.

  • Belvedere Trading reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2024 after selling out during the quarter.
  • Belvedere Trading sold 166 REVIVA PHARMA HLDGS INC shares in Q1 2024, an estimated $17.1K.
  • Belvedere Trading first reported a position in REVIVA PHARMA HLDGS INC in Q1 2023 and held it in 4 quarters.
  • Belvedere Trading's REVIVA PHARMA HLDGS INC position peaked at $242K in Q3 2023.
  • 28 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2024.

Based on Belvedere Trading's 13F filing for Q1 2024, filed 9 May 2024.